Testosterone Regulation and Autism Ranking:

History

Leuprolide was first approved by the FDA for treatment of advanced prostate cancer in 1985. Subsequent variations have been developed by various manufacturers to treat a range of other conditions, including endometriosis and precocious puberty.

It was first suggested as a treatment for inappropriate sexual behaviours in autistic people by Realmuto and Ruble in 1999.

It was then suggested as a treatment for a wide range of other problems in autistic people by M.R. Geir and D.A. Geir in 2005.

Updated

16 Jun 2022

Last Review

01 Sep 2017

Next Review

01 Jan 2024